Advertisement

Topics

US Congressmen accuse Teva of price hikes over 1,000%

05:50 EDT 21 Aug 2017 | Pharmafile

A pair of US Congressmen have fired allegations at Israeli drugmaker Teva accusing the firm of hiking the price of its multiple sclerosis treatment Copaxone (glatiramer acetate) by more than 1,000% since 1996.

Democrat Congressmen Elijah Cummings and Peter Welch have announced their intention to fully investigate Teva’s pricing practices, while also calling out a number of other firms, sending letters to Novartis, Bayer and Biogen, among others.

read more

Original Article: US Congressmen accuse Teva of price hikes over 1,000%

NEXT ARTICLE

More From BioPortfolio on "US Congressmen accuse Teva of price hikes over 1,000%"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...

Multiple Sclerosis MS
Multiple sclerosis (MS) is the most common disabling neurological condition affecting 100,000 young adults in the UK. The condition results from autoimmune damage to myelin, causing interference in nerve signaling. Symptoms experienced depend on the pa...